The heritage of glatiramer acetate and its use in multiple sclerosis | Multiple Sclerosis and Demyelinating Disorders | Full Text
Glatiramer Acetate Treatment of Multiple Sclerosis: An Immunological Perspective | The Journal of Immunology
Frontiers | The Role of B Cells in Primary Progressive Multiple Sclerosis | Neurology
Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action - The Lancet Neurology
Mechanisms of action of glatiramer acetate (GA) in MS. Reprinted from... | Download Scientific Diagram
Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis | SpringerLink
IJMS | Free Full-Text | New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration | HTML
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease
COPAXONE® Glatiramer acetate - ppt download
Overview of glatiramer acetate mechanism of action. Abbreviations: APC,... | Download Scientific Diagram
Overview of glatiramer acetate mechanism of action. Abbreviations: APC,... | Download Scientific Diagram
Mechanisms of Action of Glatiramer Acetate in the Treatment of Multiple Sclerosis - ScienceDirect
Mechanisms of mitoxantrone in multiple sclerosis–what is known? - Journal of the Neurological Sciences
A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine
Mechanisms of action of glatiramer acetate in multiple sclerosis | Neurology
Mechanisms of Action of Glatiramer Acetate in the Treatment of Multiple Sclerosis - ScienceDirect
The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis | SpringerLink
Glatiramer acetate attenuates the activation of CD4+ T cells by modulating STAT1 and −3 signaling in glia | Scientific Reports
Teriflunomide in multiple sclerosis: an update | Neurodegenerative Disease Management
Glatiramer acetate for treatment of MS: Regulatory B cells join the cast of players | Semantic Scholar
Multiple Sclerosis | NEJM
The innovative development in interferon beta treatments of relapsing‐remitting multiple sclerosis - Madsen - 2017 - Brain and Behavior - Wiley Online Library
Management of Multiple Sclerosis | NEJM
Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis | Scientific Reports
Glatiramer acetate http://db.doyma.es/cgi-bin/wdbcgi.exe/doyma/mrevista.pubmed_full?rev=19&vol=17&num=5&pag=244 Neurologia 2002 May;17(5):244-58 Comi G, Moiola L. Head of the Departments of Neurology and Neurophysiology. University Vita ...
